Trends in Computational Toxicology & Critical Success Factors for Transporter Studies- Full Interview with Tobias Noeske

By:
Posted: 06/26/2013

In this exclusive interview Tobias Noeske, Associate Principal Scientist from AstraZeneca, speaks to Andrea Charles from Pharma IQ, about the recent trends in computational toxicology and critical success factors for transporter studies in drug applications. Noeske also discusses key findings on relationship between BSEP inhibition and molecular physicochemical properties,  and why it is important for drugs not to inhibit the bile salt export protein.

To continue viewing this content please fill out the form below and become an Pharma IQ member.
Or if you're already a Pharma IQ member, sign in below to download.
Join

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.

By:
Posted: 06/26/2013

Pharma IQ Members